Artificial intelligence (AI) brought me a breakthrough regarding clinical data and computer models. Nowadays, with the development of AI significantly advances progress, we hope the researcher can utilize this modern technology to improve clinical accuracy such as diagnosis, prognosis, therapeutic, and so on. Clinical work is filled enough with patients and they need AI help to minimize workload and improve the high efficiency of the medical assignment.
Titled “Current and Prevalent Trends in Clinical Medicine with Artificial Intelligence” this book included AI application in cancer diagnosis and prognosis, AI accelerates the development and transformation of the medical care AI in China’s COVID-19 Pandemic and AI experience of fighting with the COVID-19. All readers welcome to read. In this book, you can learn the AI technology with Clinical knowledge., the latest advance of AI application in the clinic, even now, it can be applied in the COVID-19 pandemic. We are trying to collect the latest issue regarding AI in Clinical Oncology.
In preparing this book we have had the privilege of collaborating with outstanding contributors from leading comprehensive cancer and computer specialist. We believe that the authors’ expertise, distinguished pieces of knowledge, and multidisciplinary approaches provide a valuable source of information and can guide decision-making for physicians and clinical researchers.
All physicians active in the field of cancer diagnosis and treatment (oncologists, oncologic surgeons, radiation oncologists, nuclear medicine physicians, and radiologists) and computer specialists on artificial intelligence are the target audience for this book. The book can also be used to train young specialists who are preparing for a multidisciplinary crossover examination.
We dedicate this book to those who treat people with dignity and respect and to organizations and individuals committed to building a peaceful world.
Shigao Huang
Faculty of Health Science
University of Macau
Macau
China
ACKNOWLEDGEMENT
Shaanxi Jiuzhou Biomedical Science and Technology Group referred to as “Jiuzhou Group”,
founded in September 2006, is located in Xi'an Hi-tech Development Zone in China
established by Shaanxi Jiuzhou Biotechnology Co., Ltd. and Shaanxi high tech Industry
Investment Co., Ltd. Main business: research and development and transformation of cell
biotechnology, professional platform service of life science, precision medical diagnosis,
medical service, health management, etc. Jiuzhou Group began to invest in the construction of
Shaanxi Jiuzhou biomedical science and Technology Park (currently, knew as Shaanxi
Jiuzhou stem cell science and Technology Industrial Park) in 2002, which is a provincial key
construction project in the 11th five year plan. At the beginning of the 12th Five Year Plan
period, the first industrial transformation platform of cell gene was built in China (2010), and
the whole industrial chain of cell collection, storage, detection, production and preparation,
clinical research and application was built. After ten years of accumulation, the industrial
pattern of "one park, one chain and one center" has been formed in Jiuzhou stem cell science
and Technology Industrial Park, whole industrial chain of cell biology and Jiuzhou medical
center.
Xi 'an Zer Huier Education Technology Co., Ltd., founded in 2018, in China, is a professional
institution focusing on medical and health examination and training and improving the
professional ability of the pharmaceutical industry. The company has the most professional
team of teachers, all the lecturers are from domestic and foreign professional colleges and
universities. They not only have made a lot of achievements in the relevant fields, but also
have a wealth of teaching experience, focusing on the systematic training of professionals in
the field of health care, to provide more breadth, validity, and professional training services
for the field of health care in China.
